🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 3 días
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
05/05/2026 4,1200 EUR
12/05/2025 3,9200 EUR
13/05/2024 3,7600 EUR
30/05/2023 3,5600 EUR
06/05/2022 3,3300 EUR
05/05/2021 3,2000 EUR
04/05/2020 3,1500 EUR
09/05/2019 3,0700 EUR
11/05/2018 3,0300 EUR
16/05/2017 2,9600 EUR
10/05/2016 2,9300 EUR
11/05/2015 2,8500 EUR
12/05/2014 2,8000 EUR
09/05/2013 2,7700 EUR
10/05/2012 2,6500 EUR
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/03/2017 82,04 82,08 80,74 81,36 -0,79% 1,64% 2.530.471
06/03/2017 83,11 83,21 81,38 82,00 -1,36% 2,20% 2.370.566
03/03/2017 82,15 83,28 82,04 83,14 +1,15% 1,50% 2.282.112
02/03/2017 82,33 82,84 81,90 82,19 -0,22% 1,14% 1.832.336
01/03/2017 81,33 82,84 81,32 82,37 +1,83% 1,87% 2.817.899
28/02/2017 80,56 80,94 79,91 80,89 +1,12% 1,27% 2.299.311
27/02/2017 80,54 80,56 79,71 79,99 -0,19% 1,05% 1.679.130
24/02/2017 79,90 80,47 79,07 80,14 +0,56% 1,75% 2.453.263
23/02/2017 80,01 80,78 79,58 79,69 -0,17% 1,50% 1.904.119
22/02/2017 80,42 80,42 79,38 79,83 -0,32% 1,30% 2.228.715
21/02/2017 79,73 80,25 79,45 80,09 -0,02% 1,01% 2.425.862
20/02/2017 81,27 81,51 79,75 80,11 -1,15% 2,17% 1.583.042
17/02/2017 81,35 81,66 80,46 81,05 -0,17% 1,48% 2.112.135
16/02/2017 81,06 82,00 80,83 81,19 +0,53% 1,45% 2.225.947
15/02/2017 80,50 81,02 80,33 80,76 +0,87% 0,85% 2.035.823
14/02/2017 79,71 80,59 79,58 80,06 +0,15% 1,27% 1.858.315
13/02/2017 79,57 80,28 79,52 79,94 +0,29% 0,96% 1.795.049
10/02/2017 79,76 80,61 79,46 79,71 -0,05% 1,45% 2.042.566
09/02/2017 76,82 80,05 76,70 79,75 +4,62% 4,36% 3.837.761
08/02/2017 76,31 78,32 75,51 76,23 +0,99% 3,69% 3.357.477
07/02/2017 75,29 76,11 75,29 75,49 +0,34% 1,10% 2.052.256
06/02/2017 75,23 75,74 74,69 75,23 +0,03% 1,39% 1.919.427
03/02/2017 75,09 75,53 75,01 75,21 +0,85% 0,69% 1.704.407
02/02/2017 75,07 75,07 74,11 74,57 -1,06% 1,29% 2.077.561
01/02/2017 74,62 75,46 74,19 75,37 +1,73% 1,69% 2.651.551
31/01/2017 74,56 74,82 73,74 74,09 -0,40% 1,45% 3.370.421
30/01/2017 73,63 74,74 73,54 74,38 +0,40% 1,63% 2.221.668
27/01/2017 74,14 74,51 73,30 74,09 -0,17% 1,64% 2.214.793
26/01/2017 74,18 75,21 73,78 74,21 +0,51% 1,93% 2.428.769
25/01/2017 74,08 74,64 73,62 73,84 +0,47% 1,38% 2.888.340